Pricing Log in Create free account

Assembly Biosciences, Inc. (ASMB) vs Eupraxia Pharmaceuticals Inc. (EPRX)

Assembly Biosciences, Inc. and Eupraxia Pharmaceuticals Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and Eupraxia Pharmaceuticals Inc. are of similar size ($491.7M and $479.1M). Eupraxia Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 22.3×. Eupraxia Pharmaceuticals Inc. has the higher net margin (0.00% vs −0.06%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Assembly Biosciences, Inc. leads on 6 and Eupraxia Pharmaceuticals Inc. on 6.

Valuation

Metric ASMB EPRX Biotechnology median
P/E 22.32 n/m 8.56
P/S 5.74 n/m 10.17
P/B 1.40 4.84 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 1.46 n/m 9.64
Earnings yield 4.48% (13.93%) (29.41%)
Free cash flow yield (8.98%) (7.89%) (23.50%)

Profitability

Metric ASMB EPRX Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (11.75%) 0.00% 0.00%
Net margin (0.06%) 0.00% 0.00%
Free cash flow margin (51.53%) 0.00% 0.00%
Return on equity (0.03%) (117.82%) (56.66%)
Return on assets (0.02%) (64.44%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ASMB EPRX Biotechnology median
Revenue growth (TTM) 125.12% — 5.64%
EPS growth (last fiscal year) 91.78% (35.53%) 30.08%
Revenue growth, 5-year CAGR 35.27% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ASMB EPRX Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 13.99 16.00 4.72
Net debt to EBITDA 17.31 2.11 0.96

Dividend

Metric ASMB EPRX Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ASMB EPRX Biotechnology median
Market cap 479.08m 491.69m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack